TB500 (Thymosin B4 Acetate) 5mg

TB-500 Peptide for Recovery and Healing TB-500, a synthetic form of Thymosin Beta-4, is renowned for its regenerative properties. Designed to support tissue repair, reduce inflammation, and enhance muscle recovery, TB-500 plays a valuable role in aiding joint health and promoting rapid recovery from injuries. Used widely in sports and regenerative medicine, TB-500 has potential applications in muscle recovery, joint support, and reducing scar tissue. Explore our Peptides for Recovery or browse our Tissue Repair Solutions for related options. Learn more about how peptides like TB-500 can support healing and enhance athletic recovery.

3000mcg/ml subcutaneous injection provided in a 5ml vial.

“Differential expression of the human thymosin-beta 4 gene in lymphocytes, macrophages, and granulocytes.
A cDNA clone encoding human thymosin-beta 4 was blot analyses of different neoplastic B lymphocytes revealed isolated from a cDNA library prepared from peripheral that steady state levels of thymosin-beta 4 mRNA varid as a blood leukocytes of a patient with acute lymphocytic function of differentiation stage. Thymosin-beta 4 mRNA leukemia. This clone contained the entire coding sequence levels were decreased in myeloma cells as are class II of 43 amino acid residues of thymosin-beta 4 and had an human leukocyte antigen, Fc receptor, and complement initiation codon and two termination codons. The amino receptor, suggesting a relationship between thymosin-beta acid and nucleotide sequences in the coding region were 4 and the immune response. Thymosin-beta 4 mRNA well conserved between rat and human. Nine of 132 was more highly expressed in mature granulocytes than in nucleotides were different in the coding sequences (93% immature blastic cells. Treatment of THP-1 cells, a human homology), but the deduced amino acid sequences were monocytic cell line, with recombinant human interferonidentical.
No signal peptide was found in the deduced lambda reduced the levels of thymosin-beta 4 mRNA. Its protein sequence. Human thymosin-beta 4 mRNA, level decreased after differentiation of THP-1 cells into la+ approximately 830 nucleotides in length, was about 30 macrophages, but increased after differentiation of HL-60 nucleotides larger than rat thymosin-beta 4 mRNA. cells into la- macrophages. The pattern of thymosin-beta Expression of the human thymosin-beta 4 gene in various 4 gene expression suggests that it may play a fundamental primary myeloid and lymphoid malignant cells and in a role in the host defense mechanism. few human hemopoietic cell lines was studied. Northern H Gondo, J Kudo, J W White, C Barr, P Selvanayagam, G F Saunders The Journal of Immunology December 1, 1987, 139 (11) 3840-3848;”